[{"address1": "4224 Campus Point Court", "address2": "Suite 210", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 202 6300", "website": "https://www.regulusrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. The company develops farabursen, an anti-miR oligonucleotide targeting miR-17 in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. It is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. The company has a license and collaboration agreement with Alnylam Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc. to develop, manufacture, and commercialize products covered by the licensed patent rights for use in microRNA compounds. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.", "fullTimeEmployees": 34, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph P. Hagan M.B.A.", "age": 55, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1063084, "exercisedValue": 0, "unexercisedValue": 117019}, {"maxAge": 1, "name": "Dr. Preston S. Klassen M.D., M.H.S.", "age": 55, "title": "President, Head of Research & Development and Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 760760, "exercisedValue": 0, "unexercisedValue": 39950}, {"maxAge": 1, "name": "Ms. Crispina  Calsada CPA", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 669100, "exercisedValue": 0, "unexercisedValue": 35109}, {"maxAge": 1, "name": "Mr. Daniel J. Penksa", "age": 38, "title": "VP of Finance & Controller", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher Ray Aker J.D.", "age": 63, "title": "Senior VP, General Counsel & Corporate Secretary", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 575942, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Claire Susan Padgett M.S., M.T., Ph.D.", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rekha  Garg M.D., M.S.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Lee Ph.D.", "title": "Vice President of Translational Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 9, "shareHolderRightsRisk": 6, "overallRisk": 6, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.85, "open": 7.84, "dayLow": 7.83, "dayHigh": 7.86, "regularMarketPreviousClose": 7.85, "regularMarketOpen": 7.84, "regularMarketDayLow": 7.83, "regularMarketDayHigh": 7.86, "payoutRatio": 0.0, "beta": 0.498, "forwardPE": -6.4838014, "volume": 342768, "regularMarketVolume": 342768, "averageVolume": 1835262, "averageVolume10days": 5037540, "averageDailyVolume10Day": 5037540, "bid": 7.76, "ask": 7.93, "bidSize": 1, "askSize": 1, "marketCap": 542826368, "fiftyTwoWeekLow": 0.83, "fiftyTwoWeekHigh": 8.2, "fiftyDayAverage": 2.4696, "twoHundredDayAverage": 1.7449, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 445293568, "profitMargins": 0.0, "floatShares": 45763579, "sharesOutstanding": 69190400, "sharesShort": 2110119, "sharesShortPriorMonth": 2037305, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0319, "heldPercentInsiders": 0.02691, "heldPercentInstitutions": 0.82874, "shortRatio": 0.94, "shortPercentOfFloat": 0.0404, "impliedSharesOutstanding": 69190400, "bookValue": 1.166, "priceToBook": 6.728473, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -46358000, "trailingEps": -0.82, "forwardEps": -1.21, "lastSplitFactor": "1:10", "lastSplitDate": 1656460800, "enterpriseToEbitda": -8.961, "52WeekChange": 2.488889, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 7.8454, "targetHighPrice": 11.0, "targetLowPrice": 7.0, "targetMeanPrice": 8.8, "targetMedianPrice": 9.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 75777000, "totalCashPerShare": 1.144, "ebitda": -49693000, "totalDebt": 1055000, "quickRatio": 10.105, "currentRatio": 10.981, "debtToEquity": 1.381, "returnOnAssets": -0.54424, "returnOnEquity": -0.95001, "grossProfits": -35367000, "freeCashflow": -25530750, "operatingCashflow": -41673000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "RGLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1746723808, "exchange": "NCM", "messageBoardId": "finmb_36742485", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Regulus Therapeutics Inc.", "longName": "Regulus Therapeutics Inc.", "regularMarketChangePercent": -0.058599338, "regularMarketPrice": 7.8454, "marketState": "REGULAR", "cryptoTradeable": false, "regularMarketChange": -0.004600048, "regularMarketDayRange": "7.83 - 7.86", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1835262, "fiftyTwoWeekLowChange": 7.0154, "fiftyTwoWeekLowChangePercent": 8.45229, "fiftyTwoWeekRange": "0.83 - 8.2", "fiftyTwoWeekHighChange": -0.35459995, "fiftyTwoWeekHighChangePercent": -0.043243896, "fiftyTwoWeekChangePercent": 248.8889, "dividendDate": 1538611200, "earningsTimestamp": 1741896303, "earningsTimestampStart": 1746734400, "earningsTimestampEnd": 1747080000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.82, "epsForward": -1.21, "epsCurrentYear": -1.3125, "priceEpsCurrentYear": -5.9774475, "fiftyDayAverageChange": 5.3758, "fiftyDayAverageChangePercent": 2.1767898, "twoHundredDayAverageChange": 6.1005, "twoHundredDayAverageChangePercent": 3.4961889, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.5 - Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1349789400000, "displayName": "Regulus Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]